Patently Important

The U.S. Supreme Court will tackle three major patent issues in 2013, involving DNA, generic drugs, and genetically modified seeds.  According to Professor Daryl Lim of Chicago's John Marshall Law School, how genetic research gets conducted, how drugs come on the market and how our food is grown will all be impacted by SCOTUS.

http://www.todayscampus.com/article/John_Marshall_Law_School_Professor_Addresses_Three_Blockbuster_Patent_Cases_for_2013

Related articles

• Three Blockbuster Patent Cases at the Supreme Court This Term
• Three Blockbuster Patent Cases at the Supreme Court This Term
• Briefs Filed by Petitioner and His Amici in Bowman v. Monsanto
• Genetic Technologies Limited sues LabCorp and 23andMe for patent infringement
• US Supreme Court Poised To Rule Human Genes Are Not Patentable
• Gene Patents: Getting Beyond Witch Trials
• Can Companies Own Human Genes?
• Monsanto's Earnings Nearly Double as They Create a Farming Monopoly
• No more gene patents could be a "positive development"
• Loeb & Loeb Expands Patent Practice with Addition of Partner William J. Kramer in Chicago